StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 02/20/2013 -- StockRunway.com issues a special report on Most Lucrative Penny Stocks, SWINGPLANE VENTURES (OTC:SWVI) and Cord Blood America Inc. (OTC:CBAI) are discussed below:
SWINGPLANE VENTURES (OTC:SWVI)’s shares went up 19.71% during previous trading hours, after opening at the price of $0.70. Stock’s closing price for the day was $0.820. On Tuesday trading session the company’s lowest price was standing at $0.70 while it hits the highest price at $0.84. Total trading volume of the shares was 26.93 million more than double of its average trading volume of 10.58 million shares.
Can SWVI Show a Strong Recovery? Find out in This Research Report
Swingplane Venture Inc. (SWVI) has updated the information regarding its Algarrobo property. The company’s Algarrobo Property to be called as "Property" is an Iron Oxide-Copper-Gold (IOCG) property positioned almost 850 km north of Santiago, in the III Region, Province of Copiapo, Chile. The city of Copiapo is located round about 43 km to the southeast of the Property, with the small port city of Caldera 25 km to the east. The Property consists of 32 tenures, comprising a total of 15,224 acres.
Swingplane Venture Inc. (SWVI) has a total market capitalization of 297.98 million shares. If we trace the previous 6 month’s performance of the stock, it seems like a bullish runner since then, as it continuously scored a positive percentage afterwards and remained among the positive gainers.
Should SWVI a Buy or Sell Now? Find Out Here
Cord Blood America Inc. (OTC:CBAI) traded with the volume of 18.15 million shares almost doubled in comparison of its average trading volume of 9.88 million shares. Stock was moving up after ringing the bell, but after 12 Noon its shares soared massively and gained investor’s attention. The stocks remained up till closing the trade for the day its shares finally closed at $0.0034 after scoring 25.93%. CBAI’s beta value stood at -0.77 points while its total outstanding shares are 250.00 million.
How Should Investors Trade CBAI Now? Don’t Miss out a Special Trend Analysis
An over view of historical trend of the stock: stock’s year to date performance is showing a downward trend as it lost 32%, afterwards during previous 6 and 3 months the company’s shares remained in bearish zone, but if we trace the company’s performance in last one month and 5 day’s it soared and gain an upward momentum of 25.93% and 6.25% respectively.
Cord Blood America Inc. (CBAI) is primarily an umbilical cord blood stem cell preservation company, with a particular focus on the acquisition of customers in need of family based products and services.
What CBAI’s Charts Are Signaling for Traders? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)